InvestorsHub Logo
Followers 1054
Posts 189434
Boards Moderated 1
Alias Born 06/19/2009

Re: None

Thursday, 05/16/2013 11:34:23 AM

Thursday, May 16, 2013 11:34:23 AM

Post# of 554
FDA PLAYER NGSXE .015 WILL BE 0.50 WHEN/IF DRUG APPROVED:


knulp


Thursday, May 16, 2013 11:01:37 AM
Re: ash111 post# 3009360

Post # of 3009457


FDA PLAYER NGSXE .015 WILL BE 0.50 WHEN/IF DRUG APPROVED,REMEMBER DRUG WAS ALREADY APPROVED,PH3 FOR FURTHER INDICATION LED BY ACORDA, IN CASE OF APPROVAL A LOT OF MONEY TO NGSXE AND COMMONS, COMPANY ISN'T IN BANKRUPTCY BUT SOLD MOST OF ITS ASSETS TO ACORDA FOR MONEY,POTENTIAL ROYALTIES, BATGAIN ATHESE PPS IMO

NGSXE .015$ 33M OS 10M FLOAT NOBRAINER,FDA PLAYER, ONGOGOING PH3 PLUS FDA APPROVED DRUGS,SOLD TO ACORDA BUT MAY BE ENTITLED TO BIG ROYALTIES IF APPROVAL COMES IN NEXT YEARS,MARKET CAP 400K $ WAS MULTI DOLLAR PLAYER,AT 0.05 MARKET CAP COULD BE LESS THAN 2MLN$ FOR A MULTI MILLION $ DRUG AND ROYALTIES,NO BANKRUPTCY HERE, REGULATORY NEWS MAY COME AT ANY MOMENT

alert NGSXE PPS MAY STABILIZE AROUND .05 OR 1.6MLN$ MC, ACORDA THERAPEUTICS WILL RELEASE KEY DATA AND REGULATORY DECISIONS IN NEXT WEEKS/MONTHS/YEARS,EVERY PH3 ADVANCEMENT WILL PUSH PPS IMHO,ONE OF THE BIGGEST MARKET MISS, TILL .05 VERY LOW RESISTANCE

My posts are my opinion and should not be used as investment advice. Make your own decisions in your stock trades.

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.